Patents by Inventor Anne A. Gershon

Anne A. Gershon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Genetically engineered cell lines and systems for propagating varicella zoster virus and methods of use thereof
    Publication number: 20080279888
    Abstract: The present invention provides genetically engineered cell lines, recombinant vectors, and vaccines. The present invention also provides methods for generating an in vitro system for Varicella zoster virus (VZV), and the in vitro systems generated by these methods. The present invention further provides methods for reactivating VZV, and VZV reactivated by these methods. Finally, the present invention provides a method of screening for an agent for treating VZV infection.
    Type: Application
    Filed: September 24, 2007
    Publication date: November 13, 2008
    Applicant: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
    Inventors: Michael D. Gershon, Zhenglun Zhu, Saul Silverstein, Anne A. Gershon
  • Genetically engineered cell lines and systems for propagating virus and methods of use thereof
    Patent number: 7273616
    Abstract: The present invention provides genetically engineered cell lines, recombinant vectors, and vaccines. The present invention also provides methods for generating an in vitro system for Varicella zoster virus (VZV), and the in vitro systems generated by these methods. The present invention further provides methods for reactivating VZV, and VZV reactivated by these methods. Finally, the present invention provides a method of screening for an agent for treating VZV infection.
    Type: Grant
    Filed: May 12, 2003
    Date of Patent: September 25, 2007
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Jason J. Chen, Anne A. Gershon, Zhenglun Zhu, Saul Silverstein, Michael D. Gershon
  • Genetically engineered cell lines and systems for propagating Varicella zoster virus and methods of use thereof
    Publication number: 20060121048
    Abstract: The present invention provides genetically engineered cell lines, recombinant vectors, and vaccines. The present invention also provides methods for generating an in vitro system for Varicella zoster virus (VZV), and the in vitro systems generated by these methods. The present invention further provides methods for reactivating VZV, and VZV reactivated by these methods. Finally, the present invention provides a method of screening for an agent for treating VZV infection.
    Type: Application
    Filed: May 12, 2003
    Publication date: June 8, 2006
    Inventors: Jason Chen, Anne Gershon, Zhenglun Zhu, Saul Silverstein, Michael Gershon
  • VZV ORF29p protein-related compositions and methods
    Patent number: 6809182
    Abstract: The present invention provides compositions of matter comprising 29p protein having bound thereto an agent whose delivery into a eukaryotic cell is desired. The present invention also provides a monoclonal antibody which specifically binds to 29p protein. The present invention further provides methods for delivering an agent into a eukaryotic cell, and methods for causing a eukaryotic cell to secrete a desired protein in the form of a fusion protein. The present invention further provides 29p protein-containing pharmaceutical compositions. The present invention still further provides nucleic acid molecules which hybridize to at least a portion of a nucleic acid molecule encoding 29p protein. Finally, the present invention provides methods for detecting the presence of, and quantitatively determining the amount of, a 29p protein-encoding nucleic acid molecule in a sample.
    Type: Grant
    Filed: January 25, 2001
    Date of Patent: October 26, 2004
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Saul J. Silverstein, Paula W. Annuziato, Anne A. Gershon, Octavian Lungu
  • VZV ORF29p protein-related compositions and methods
    Publication number: 20010039051
    Abstract: The present invention provides compositions of matter comprising 29p protein having bound thereto an agent whose delivery into a eukaryotic cell is desired. The present invention also provides a monoclonal antibody which specifically binds to 29p protein. The present invention further provides methods for delivering an agent into a eukaryotic cell, and methods for causing a eukaryotic cell to secrete a desired protein in the form of a fusion protein. The present invention further provides 29p protein-containing pharmaceutical compositions. The present invention still further provides nucleic acid molecules which hybridize to at least a portion of a nucleic acid molecule encoding 29p protein. Finally, the present invention provides methods for detecting the presence of, and quantitatively determining the amount of, a 29p protein-encoding nucleic acid molecule in a sample.
    Type: Application
    Filed: January 25, 2001
    Publication date: November 8, 2001
    Inventors: Saul J. Silverstein, Paula W. Annunziato, Anne A. Gershon, Octavian Lungu